---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-032629"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:19:03.727946+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oragenics CFO Michael Sullivan resigns effective Dec 14, 2022

## Summary
- CFO Michael Sullivan notified company of resignation effective December 14, 2022.
- Resignation is to pursue other opportunities; not due to any disagreement with the company.
- Sullivan will remain through Dec 14 to facilitate orderly transition.
- Company expects to promptly begin a search for Sullivan's successor.

## SEC filing metadata
- accession: 0001493152-22-032629
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315222032629/0001493152-22-032629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315222032629/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-032629
- JSON: https://secwatch.observer/filing/0001493152-22-032629.json
- Plain text: https://secwatch.observer/filing/0001493152-22-032629.txt

## Key facts
- Executive change
  Michael Sullivan departed as Chief Financial Officer at ORAGENICS INC.
  - Action: resigning
  - Role: Chief Financial Officer
  source text: On November 16, 2022, Michael Sullivan, the Chief Financial Officer of Oragenics (the “Company”) notified the Company that he would be resigning from the Company, effective December 14, 2022, to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315222032629/0001493152-22-032629-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.